Who We Are
Backed by the ELV Group
As Brunex, a part of the multimillion-dollar ELV conglomerates, one of India’s largest and most diversified conglomerates, we leverage a strong legacy of excellence, financial stability and a global network to drive innovation and quality in pharmaceuticals.
- Brunex Pharmaceuticals is an integrated, rapidly expanding pharmaceutical company supplying a wide range of pharmaceuticals to South East Asia, CIS countries, Latin America, and African countries, with direct presence in Canada, Ivory Coast, Philippines, Uzbekistan and Ukraine.
- Our major focus is on high quality Oncology, Higher Antibiotics, Anesthetics and other super specialty Products. We aim to be recognized as a leader in these areas.
- We develop wide range of super specialty formulations couples with our own API and niche services with inhouse R&D.
- We ensure high quality standards and continuity of supply are of vital importance for hospitals/health care Institutions.


Quality Policy
Our Principle “Quality is an habit, not act.“
We are committed to develop and supply, high quality drug formulations in order to meet the our customers and Patients satisfaction globally.


Want to Learn More About Us?
Discover the story behind Brunex Pharmaceuticals, our commitment to quality, innovation and global healthcare leadership.
Download our Company Profile
Making a Difference, Together








Our Board of Directors

Dr. Bhaskar Erugandindla
Chairman
The Chairman of ELV Group, which also encompasses Brunex Pharmaceuticals as part of its
diversified conglomerate.
A pioneering force whose strategic foresight and unwavering dedication have been
the cornerstone of the Group’s growth. With deep business insight and a passion for
purposeful development, he has expanded ELV into a multi-sector enterprise spanning
real estate, education, hospitality, pharmaceuticals, mining, retail, entertainment, food
processing Laboratories, and security services.
His people-first approach, commitment to quality, and focus on innovation continue to
drive ELV’s legacy of trust, excellence, and sustainable progress—building a better
tomorrow, one transformative venture at a time.

Veera kumar Reddy Oleti
Vice Chairman
A visionary leader who blends tradition with breakthrough innovation.
His entrepreneurial spirit has driven the Group’s expansion into Real Estate, Education,
Hospitality, pharmaceuticals, Entertainment, Food processing Laboratories.
Under his leadership, bold ideas become landmark Real Estate projects that integrate
sustainable luxury, advanced technology, and lasting social impact—redefining upscale
living, enhancing global healthcare, and nurturing future generations.
Guided by integrity and innovation, his legacy continues to build a vibrant future for all.

Mallikarjun C Bidari
Director - Global Business
Brunex Pharmaceuticals is the brainchild of Mallikarjun Bidari, who holds a Master’s degree in Pharmaceutics and Intellectual Property Rights from IISc Bangalore.
With over 20 years of experience, he has specialized expertise in international business development, CDMO operations, and portfolio management across global markets including Europe, Australia and New Zealand. His extensive background encompasses establishing worldwide distribution networks, managing complex projects, setting up global regulatory frameworks and developing end-to-end supply chain solutions – from large multinational corporations to startups.

Siddesh KM
Director - Operations
A First-Generation Entrepreneur who played a key role in shaping Brunex Pharmaceutical’s journey. Holding a Master Degree in Pharmacology from Rajiv Ghandi University of Health Sciences, Bangalore. In-depth knowledge of Pharmaceutical Industry understanding of Drug Development Process, Regulatory Compliance, Market dynamics, Operations & Project Management.
A visionary to address unmet medical needs or improve existing treatments. Ensuring a strong focus on quality and safety in all aspects of pharmaceutical operations.